NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,839,478 | -12.6% | 64,169 | -3.9% | 0.01% | -9.1% |
Q2 2023 | $3,249,953 | -12.4% | 66,789 | 0.0% | 0.01% | -15.4% |
Q1 2023 | $3,708,125 | +31.3% | 66,789 | -5.0% | 0.01% | +18.2% |
Q4 2022 | $2,824,072 | +3.9% | 70,303 | +13.3% | 0.01% | 0.0% |
Q3 2022 | $2,719,000 | +16.1% | 62,040 | -6.1% | 0.01% | +22.2% |
Q2 2022 | $2,342,000 | +6.0% | 66,097 | +21.7% | 0.01% | +28.6% |
Q1 2022 | $2,210,000 | -52.9% | 54,323 | +8.1% | 0.01% | -50.0% |
Q4 2021 | $4,693,000 | -12.5% | 50,247 | +4.5% | 0.01% | -17.6% |
Q3 2021 | $5,361,000 | -1.2% | 48,103 | +0.6% | 0.02% | -5.6% |
Q2 2021 | $5,428,000 | +17.5% | 47,812 | +5.1% | 0.02% | +12.5% |
Q1 2021 | $4,621,000 | +2.5% | 45,507 | +0.5% | 0.02% | 0.0% |
Q4 2020 | $4,507,000 | +28.9% | 45,286 | -6.4% | 0.02% | +14.3% |
Q3 2020 | $3,496,000 | +39.8% | 48,401 | -3.5% | 0.01% | +40.0% |
Q2 2020 | $2,500,000 | +50.6% | 50,132 | -9.8% | 0.01% | +25.0% |
Q1 2020 | $1,660,000 | -11.4% | 55,603 | 0.0% | 0.01% | +14.3% |
Q4 2019 | $1,873,000 | – | 55,603 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |